BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33146392)

  • 1. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
    Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
    J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Veteran Status Mitigate Racial Disparities in Prostate Cancer Screening? Analysis of Prostate Specific Antigen Screening Patterns in the 2018 Behavioral Risk Factor Surveillance System Data.
    Alkhatib K; Labban M; Briggs L; Nguyen DD; Herzog P; Cole AP; Haag A; Trinh QD
    J Urol; 2022 May; 207(5):993-1000. PubMed ID: 34967663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
    Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
    Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    Bassett MT; Chen JT; Krieger N
    PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
    Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
    Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
    Lai SM; Keighley J; Garimella S; Enko M; Parker WP
    JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insufficient Lycopene Intake Is Associated With High Risk of Prostate Cancer: A Cross-Sectional Study From the National Health and Nutrition Examination Survey (2003-2010).
    Lu Y; Edwards A; Chen Z; Tseng TS; Li M; Gonzalez GV; Zhang K
    Front Public Health; 2021; 9():792572. PubMed ID: 34966715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.
    Hung MC; Ekwueme DU; Rim SH; White A
    Cancer Epidemiol; 2016 Dec; 45():112-118. PubMed ID: 27792934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
    Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
    Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
    Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020.
    Qian Z; Al Khatib K; Chen X; Belani S; Labban M; Lipsitz S; Cole AP; Iyer HS; Trinh QD
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36708009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population.
    Hines L; Zhu D; DeMasi M; Babar M; Chernyak V; Kovac EZ; Aboumohamed A; Sankin A; Agalliu I; Watts KL
    J Urol; 2021 Sep; 206(3):586-594. PubMed ID: 33881932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.
    Wu X; Wang Y; Lin X; Wang Z; Xu J; Lv W; Hu J
    Clin Lung Cancer; 2020 May; 21(3):e171-e181. PubMed ID: 31787547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
    Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
    Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.